Identification of the Porcine Vascular Endothelial Cell-Specific Promoter ESAM1.0 Using Transcriptome Analysis
Author:
Kim Sang Eun1, Sun Wu-Sheng12, Oh Miae1, Lee Seunghoon1, No Jin-Gu1, Lee Haesun1, Lee Poongyeon1, Oh Keon Bong1ORCID
Affiliation:
1. Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration, Jeonju-si 55365, Jeollabuk-do, Republic of Korea 2. College of Veterinary Medicine, Jilin Agricultural University, Changchun 130118, China
Abstract
The vascular endothelium of xenografted pig organs represents the initial site of rejection after exposure to recipient immune cells. In this study, we aimed to develop a promoter specific to porcine vascular endothelial cells as a step toward overcoming xenograft rejection. Transcriptome analysis was performed on porcine aortic endothelial cells (PAECs), ear skin fibroblasts isolated from GGTA knockout (GTKO) pigs, and the porcine renal epithelial cell line pk-15. RNA sequencing confirmed 243 differentially expressed genes with expression changes of more than 10-fold among the three cell types. Employing the Human Protein Atlas database as a reference, we identified 34 genes exclusive to GTKO PAECs. The endothelial cell-specific adhesion molecule (ESAM) was selected via qPCR validation and showed high endothelial cell specificity and stable expression across tissues. We selected 1.0 kb upstream sequences of the translation start site of the gene as the promoter ESAM1.0. A luciferase assay revealed that ESAM1.0 promoter transcriptional activity was significant in PAECs, leading to a 2.8-fold higher level of expression than that of the porcine intercellular adhesion molecule 2 (ICAM2) promoter, which is frequently used to target endothelial cells in transgenic pigs. Consequently, ESAM1.0 will enable the generation of genetically modified pigs with endothelium-specific target genes to reduce xenograft rejection.
Funder
Rural Development Administration, Republic of Korea
Subject
Genetics (clinical),Genetics
Reference36 articles.
1. Tritschler, H., Fischer, K., Seissler, J., Fiedler, J., Halbgebauer, R., Huber-Lang, M., Schnieke, A., and Brenner, R.E. (2021). New Insights into Xenotransplantation for Cartilage Repair: Porcine Multi-Genetically Modified Chondrocytes as a Promising Cell Source. Cells, 10. 2. Lu, T.-Y., Xu, X.-L., Du, X.-G., Wei, J.-H., Yu, J.-N., Deng, S.-L., and Qin, C. (2022). Advances in Innate Immunity to Overcome Immune Rejection during Xenotransplantation. Cells, 11. 3. Xenotransplantation: How close are we?;Aschheim;Nat. Biotechnol.,2023 4. Hryhorowicz, M., Lipinski, D., Hryhorowicz, S., Nowak-Terpilowska, A., Ryczek, N., and Zeyland, J. (2020). Application of Genetically Engineered Pigs in Biomedical Research. Genes, 11. 5. Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting in humans;Good;Transplant. Proc.,1992
|
|